Hi Dryasachip,
https://www.tga.gov.au/sites/default/files/2022-09/guidance-for-asx-announcements.pdf
I strongly recommend all shareholders to review this document. It is not too difficult to read and explains what is acceptable and unacceptable in ASX announcements.
PharmAust are simply following the guidelines.
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1435
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.3¢ | $108.2K | 647.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 109170 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 117939 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |